ESC Premium Access

Progress in stroke prevention in atrial fibrillation

Event: ESC CONGRESS 2017
Topic: Atrial fibrillation (AF)
Session type: Moderated Posters
Date: 28 August 2017
Time: 15:35 - 16:25


7 presentations in this session

Adherence to anticoagulant drugs in patients with atrial fibrillation and stroke in real clinical practice

Speaker: Professor D. Duplyakov (Samara, RU)

Outcomes in vitamin K antagonist treated atrial fibrillation patients with stable international normalized ratios

Speaker: Doctor A. Nissen Bonde (Gentofte, DK)

Periprocedural anticoagulation is associated with the risk of thromboembolism after elective cardioversion of atrial fibrillation.

Speaker: Doctor T. Hellman (Turku, FI)

Reduced fibrin clot permeability is associated with an increased risk of both ischemic stroke and major bleeding in atrial fibrillation patients treated with vitamin k antagonists

Speaker: Professor A. Undas (Krakow, PL)

The impact of age on the effectiveness and safety of the NOACs versus warfarin for stroke prevention in atrial fibrillation

Speaker: Doctor P. Noseworthy (Rochester, US)

Use of novel oral anticoagulants in patients with atrial fibrillation and moderate to severe renal dysfunction: findings from a prospective national registry

Speaker: Professor I. Goldenberg (Rochester, US)

Effectiveness and safety of direct oral anticoagulants compared to vitamin-k antagonists: results from a cohort study in the nationwide french claims and hospitalisation database (SNIIRAM)

Speaker: Professor Y. Cottin (Dijon, FR)

7 speakers from this session

Professor Dmitry Duplyakov

Samara Regional Cardiology Center, Samara (Russian Federation)
1 presentation
0 follower

Doctor Anders Nissen Bonde

Gentofte University Hospital, Gentofte (Denmark)
0 follower

Doctor Tapio August Hellman

Turku University Hospital, Turku (Finland)
0 follower

Professor Anetta Undas

Jagiellonian University, Krakow (Poland)
0 follower

Doctor Peter Noseworthy

Mayo Clinic, Rochester (United States of America)
1 presentation
0 follower

Professor Ilan Goldenberg

University of Rochester, Rochester (United States of America)
3 presentations
1 follower

Professor Yves Cottin

University Hospital Center (CHU) Dijon, Dijon (France)
0 follower

This platform is supported by

logo Novo Nordisk